Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    women's health

    Endometrial cancer

    Also known as: Cancer of the endometrium, Endometrial carcinoma, Uterine endometrial cancer, Endometrial adenocarcinoma

    Endometrial carcinoma originates in the uterine lining and necessitates specialist gynaecological oncology management for staging and intervention. Abnormal vaginal bleeding, particularly postmenopausal haemorrhage, requires immediate medical investigation to exclude malignancy before considering traditional pattern management. Standard protocols include surgery, radiotherapy, or systemic therapies based on tumour stage. Traditional Chinese Medicine serves as an adjunctive modality for the management of treatment-induced sequelae rather than as a primary therapy for the malignancy. Current evidence indicates acupuncture may reduce chemotherapy-induced nausea and vomiting (CINV) across various malignancies, though specific efficacy for endometrial cancer is not established within the cited evidence. Research concerning perimenopause and PCOS does not confirm therapeutic benefit or hormonal safety for this specific malignancy, and the included erratum provides no applicable data. TCM patterns reflect traditional frameworks for symptom management rather than oncological subtypes; the safety and pharmacological efficacy of herbal interventions in this cohort remain unproven.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a symptom diary documenting bleeding, nausea, bowel changes, sleep quality or disruption, and the administration of prescribed rescue medications.
    • •Optimise nutritional and fluid intake as tolerated; request an early dietetic referral if there is a significant reduction in appetite or involuntary weight loss.
    • •Engage in low-intensity physical activity consistent with postoperative restrictions and the prescribed oncology rehabilitation protocol.
    • •Attend all scheduled gynaecological oncology follow-up consultations and provide a comprehensive list of all herbs, supplements, and pharmaceutical agents at each review.

    Cautions & Contraindications

    See sources
    • •Do not replace or delay diagnostic investigation, surgery, radiotherapy, systemic therapy or prescribed antiemetics with acupuncture or herbs. Reference 2 evaluates adjunctive chemotherapy symptom care, not cancer control.[]
    • •Obtain oncology clearance before needling with neutropenia, thrombocytopenia, anticoagulation or poor wound healing; defer during suspected infection or active significant bleeding. These are general precautions: the supplied review does not define safe blood-count thresholds.[]
    • •Do not infer hormonal safety, cancer prevention or recurrence reduction from perimenopause or PCOS acupuncture results. Avoid initiating purported hormone-modifying treatment without oncology assessment; these studies concern different populations.[,]

    When to reassess or seek care again

    See sources

    Record baseline nausea on a 0–10 scale, vomiting episodes per 24 hours, rescue antiemetic use, oral intake, fatigue and sleep disruption. Review within one chemotherapy cycle or 1–2 weeks, and check adverse effects at every visit. Continue only with meaningful patient-reported benefit and acceptable safety. Refer promptly for worsening symptoms, declining intake or function, or new bleeding; escalate red flags immediately rather than waiting for review.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Translational cancer research · 2026
    2. Frontiers in neurology · 2026
    3. Frontiers in neurology · 2025
    4. International journal of women's health · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.